Exclusive

Publication

Byline

Location

Summit Therapeutics Stock Rises 11%

India, Sept. 3 -- Summit Therapeutics Inc. (SMMT) shares are currently trading at $16.24, up $1.64, or 11.23 percent on Thursday, likely supported by positive overall survival results from the Phase I... Read More


U.S. Stocks Sharply Higher Amid Easing Likelihood Of Rate Hike

India, Sept. 3 -- Stocks have moved sharply higher over the course of the trading day on Thursday, adding to gains posted in the previous session. The major averages have all shown strong moves to the... Read More


TraceLink, Omnicell Integrate DSCSA Compliance Into Hospital Pharmacy Workflows

India, Sept. 3 -- Omnicell, Inc. (OMCL), a healthcare technology company focused on autonomous medication management, announced an integration with TraceLink's Drug Supply Chain Security Act (DSCSA) c... Read More


Commerzbank To Buy Back Up To €1.2 Bln Of Shares

India, Sept. 3 -- Commerzbank AG (1CBK.MI,CBK.DE,CRZBY) on Thursday said its Board of Managing Directors has approved a further share buyback of up to €1.2 billion, starting September 4, 2026, w... Read More


OCI Global Faces Petition Over Orascom Deal

India, Sept. 3 -- OCI Global N.V. (OCINY.PK,OCI.AS), announced on Thursday that it has received a petition filed by Value8 N.V. with the Enterprise Chamber of the Amsterdam Court of Appeal seeking an ... Read More


United Imaging Receives CE Mark For Dual Wide-Coverage CT Systems

India, Sept. 3 -- United Imaging Healthcare Co., Ltd. (UIH), a publicly listed company on the Shanghai Stock Exchange STAR Market, announced that it has received CE Mark certification for its uCT Siri... Read More


Ciena Stock Falls 11% Despite Strong Q3 Earnings

India, Sept. 3 -- Ciena Corporation (CIEN) shares are currently trading at $316.47, down $37.69, or 10.64 percent on Thursday, despite the company reporting a sharp increase in third-quarter earnings ... Read More


Milestone Gets China Approval For Etripamil Nasal Spray

India, Sept. 3 -- Milestone Pharmaceuticals (MIST) on Thursday announced that China's National Medical Products Administration has approved etripamil nasal spray for treating paroxysmal supraventricul... Read More


Eikon Therapeutics Appoints Ching-Pin Chang As Executive VP & Chief Scientific Officer

India, Sept. 3 -- Eikon Therapeutics, Inc. (EIKN), a late-stage clinical biopharmaceutical company, on Thursday announced the appointment of Dr. Ching-Pin Chang as Executive Vice President and Chief S... Read More


FibroBiologics Secures U.S. Patent For Fibroblast-Based Wound Healing Therapy; Stock Down

India, Sept. 3 -- FibroBiologics, Inc. (FBLG) announced that the U.S. Patent and Trademark Office has issued Patent No. 12,721,866 covering the therapeutic use of fibroblasts and fibroblast-derived ma... Read More